Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA-Based Therapeutics and Vaccines market report explains the definition, types, applications, major countries, and major players of the RNA-Based Therapeutics and Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sylentis
Arbutus Biopharma
Dicerna Pharmaceuticals
MiRagen Therapeutics
Regulus Therapeutics
Quark Pharmaceuticals
Roche
Marina Biotech
CureVac
Moderna Therapeutics
BioNTech
Arrowhead Pharmaceuticals
Alnylam Pharmaceuticals
By Type:
RNA-Based Therapeutics
RNA-Based Vaccines
By End-User:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global RNA-Based Therapeutics and Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 RNA-Based Therapeutics and Vaccines Outlook to 2028- Original Forecasts
-
2.2 RNA-Based Therapeutics and Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term RNA-Based Therapeutics and Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global RNA-Based Therapeutics and Vaccines Market- Recent Developments
-
6.1 RNA-Based Therapeutics and Vaccines Market News and Developments
-
6.2 RNA-Based Therapeutics and Vaccines Market Deals Landscape
7 RNA-Based Therapeutics and Vaccines Raw Materials and Cost Structure Analysis
-
7.1 RNA-Based Therapeutics and Vaccines Key Raw Materials
-
7.2 RNA-Based Therapeutics and Vaccines Price Trend of Key Raw Materials
-
7.3 RNA-Based Therapeutics and Vaccines Key Suppliers of Raw Materials
-
7.4 RNA-Based Therapeutics and Vaccines Market Concentration Rate of Raw Materials
-
7.5 RNA-Based Therapeutics and Vaccines Cost Structure Analysis
-
7.5.1 RNA-Based Therapeutics and Vaccines Raw Materials Analysis
-
7.5.2 RNA-Based Therapeutics and Vaccines Labor Cost Analysis
-
7.5.3 RNA-Based Therapeutics and Vaccines Manufacturing Expenses Analysis
8 Global RNA-Based Therapeutics and Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global RNA-Based Therapeutics and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global RNA-Based Therapeutics and Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global RNA-Based Therapeutics and Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global RNA-Based Therapeutics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA-Based Therapeutics and Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immunology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Genetic Diseases Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise RNA-Based Therapeutics and Vaccines Market Analysis and Outlook till 2022
-
10.1 Global RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.2.2 Canada RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.2.3 Mexico RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.2 UK RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.3 Spain RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.4 Belgium RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.5 France RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.6 Italy RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.7 Denmark RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.8 Finland RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.9 Norway RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.10 Sweden RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.11 Poland RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.12 Russia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.3.13 Turkey RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.2 Japan RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.3 India RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.4 South Korea RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.8 Thailand RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.9 Singapore RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.11 Philippines RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.2 Colombia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.3 Chile RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.4 Argentina RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.6 Peru RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6.3 Oman RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6.4 Qatar RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.7.2 South Africa RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.7.3 Egypt RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.7.4 Algeria RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand RNA-Based Therapeutics and Vaccines Consumption (2017-2022)
11 Global RNA-Based Therapeutics and Vaccines Competitive Analysis
-
11.1 Sylentis
-
11.1.1 Sylentis Company Details
-
11.1.2 Sylentis RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sylentis RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.1.4 Sylentis RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Arbutus Biopharma
-
11.2.1 Arbutus Biopharma Company Details
-
11.2.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.2.4 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Dicerna Pharmaceuticals
-
11.3.1 Dicerna Pharmaceuticals Company Details
-
11.3.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.3.4 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 MiRagen Therapeutics
-
11.4.1 MiRagen Therapeutics Company Details
-
11.4.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.4.4 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Regulus Therapeutics
-
11.5.1 Regulus Therapeutics Company Details
-
11.5.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.5.4 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Quark Pharmaceuticals
-
11.6.1 Quark Pharmaceuticals Company Details
-
11.6.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.6.4 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Roche
-
11.7.1 Roche Company Details
-
11.7.2 Roche RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Roche RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.7.4 Roche RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Marina Biotech
-
11.8.1 Marina Biotech Company Details
-
11.8.2 Marina Biotech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.8.4 Marina Biotech RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 CureVac
-
11.9.1 CureVac Company Details
-
11.9.2 CureVac RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 CureVac RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.9.4 CureVac RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Moderna Therapeutics
-
11.10.1 Moderna Therapeutics Company Details
-
11.10.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.10.4 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 BioNTech
-
11.11.1 BioNTech Company Details
-
11.11.2 BioNTech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 BioNTech RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.11.4 BioNTech RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Arrowhead Pharmaceuticals
-
11.12.1 Arrowhead Pharmaceuticals Company Details
-
11.12.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.12.4 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Alnylam Pharmaceuticals
-
11.13.1 Alnylam Pharmaceuticals Company Details
-
11.13.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
11.13.4 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global RNA-Based Therapeutics and Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global RNA-Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise RNA-Based Therapeutics and Vaccines Market Analysis and Outlook to 2028
-
13.1 Global RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand RNA-Based Therapeutics and Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of RNA-Based Therapeutics and Vaccines
-
Figure of RNA-Based Therapeutics and Vaccines Picture
-
Table Global RNA-Based Therapeutics and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global RNA-Based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Immunology Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Table North America RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure United States RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure Germany RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure China RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure Brazil RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania RNA-Based Therapeutics and Vaccines Consumption by Country (2017-2022)
-
Figure Australia RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand RNA-Based Therapeutics and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Sylentis Company Details
-
Table Sylentis RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sylentis RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Sylentis RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Arbutus Biopharma Company Details
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Dicerna Pharmaceuticals Company Details
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table MiRagen Therapeutics Company Details
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Regulus Therapeutics Company Details
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Quark Pharmaceuticals Company Details
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Roche Company Details
-
Table Roche RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Roche RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Marina Biotech Company Details
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table CureVac Company Details
-
Table CureVac RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CureVac RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table CureVac RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Moderna Therapeutics Company Details
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table BioNTech Company Details
-
Table BioNTech RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioNTech RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table BioNTech RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Arrowhead Pharmaceuticals Company Details
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
Table Alnylam Pharmaceuticals Company Details
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Main Business and Markets Served
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Portfolio
-
Figure Global RNA-Based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-Based Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania RNA-Based Therapeutics and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand RNA-Based Therapeutics and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
